The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
Abstract
During prion disease, an increase in misfolded prion protein (PrP) generated by prion replication leads to sustained overactivation of the branch of the unfolded protein response (UPR) that controls the initiation of protein synthesis. This results in persistent repression of translation, resulting in the loss of critical proteins that leads to synaptic failure and neuronal death. We have previously reported that localized genetic manipulation of this pathway rescues shutdown of translation and prevents neurodegeneration in a mouse model of prion disease, suggesting that pharmacological inhibition of this pathway might be of therapeutic benefit. We show that oral treatment with a specific inhibitor of the kinase PERK (protein kinase RNA-like endoplasmic reticulum kinase), a key mediator of this UPR pathway, prevented UPR-mediated translational repression and abrogated development of clinical prion disease in mice, with neuroprotection observed throughout the mouse brain. This was the case for animals treated both at the preclinical stage and also later in disease when behavioral signs had emerged. Critically, the compound acts downstream and independently of the primary pathogenic process of prion replication and is effective despite continuing accumulation of misfolded PrP. These data suggest that PERK, and other members of this pathway, may be new therapeutic targets for developing drugs against prion disease or other neurodegenerative diseases where the UPR has been implicated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, the oral administration of highly selective PERK inhibitors significantly reduces neurodegeneration and clinical disease in prion-infected mice, crossing the BBB efficiently [402,403].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [402]
Citations
Cites
1 retracted
Atkin, J. D., Farg, M. A., Walker, A. K., McLean, C., Tomas, D., & Horne, M. K. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.009 · Cited by 350
RetractedSignal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,431
Regulated Translation Initiation Controls Stress-Induced Gene Expression in Mammalian Cells
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R. C., Schapira, M., & Ron, D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00108-8 · Cited by 3,344
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Harding, H. P., Zeng, H., Zhang, Y., Jungries, R., Chung, P., Plesken, H., Sabatini, D. D., & Ron, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00264-7 · Cited by 1,217
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G. R., Dickinson, A., Linehan, J. M., Klöhn, P., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 783
Self-citationTranslational Regulation of Gene Expression during Conditions of Cell Stress
Spriggs, K. A., Bushell, M., & Willis, A. E. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.028 · Cited by 748
Self-citationAxten, J. M., Medina, J. R., Feng, Y., Shu, A. Y. L., Romeril, S. P., Grant, S. W., Li, W. H. H., Heerding, D. A., Minthorn, E. A., Mencken, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300713s · Cited by 620
Self-citationSustained translational repression by eIF2α-P mediates prion neurodegeneration
Moreno, J. A., Radford, H. E., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., Halliday, M., Morgan, J., Dinsdale, D. D., Ortori, C. A., et al. (2012) · Nature · doi:10.1038/nature11058 · Cited by 616
Self-citationThe Unfolded Protein Response Is Activated in Pretangle Neurons in Alzheimer's Disease Hippocampus
Hoozemans, J. J. M., van Haastert, E. S., Nijholt, D. A. T., Rozemuller, A. J. M., Eikelenboom, P., & Scheper, W. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080814 · Cited by 600
Cited by
Sorted by citations
Items 401–500 of 582
Moon, S., Lim, J. Y., Lee, M., Han, Y., Kim, H., Kwon, W., Jang, J., Kim, M., Park, K. S., & Jung, H. S. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0366 · Cited by 9
The ER Stress Induced in Human Neuroblastoma Cells Can Be Reverted by Lumacaftor, a CFTR Corrector
Pecoraro, M., Serra, A., Pascale, M. C., & Franceschelli, S. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46090553 · Cited by 9
Yang, S., Zhang, H., Sun, X., Chen, Z., Nie, Z., Li, Y., Liu, X., Kong, Y., Wang, Z., Zai, W., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103905 · Cited by 9
Lahiri, A., Walton, J. C., Zhang, N., Billington, N., DeVries, A. C., & Meares, G. P. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25224 · Cited by 10
Doxycycline for Creutzfeldt-Jakob disease: a failure, but a step in the right direction
Geschwind, M. D. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70001-8 · Cited by 9
Ilyinsky, N. S., Nesterov, S. V., Shestoperova, E. I., Fonin, A. V., Uversky, V. N., & Gordeliy, V. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921030056 · Cited by 9
Proteostasis deregulation as a driver of C9ORF72 pathogenesis
Torres, P., Cabral‐Miranda, F., Gonzalez‐Teuber, V., & Hetz, C. A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15529 · Cited by 9
Shah, S. Z. A., Zhao, D., Taglialatela, G., Hussain, T. A., Dong, H., Sabir, N., Mangi, M. H., Wu, W., Lai, M., Zhang, X., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051144 · Cited by 9
Sepulveda, M., Rozas, P., Hetz, C. A., & Medinas, D. B. (2016) · Prion · doi:10.1080/19336896.2015.1129485 · Cited by 9
ER stress tolerance is regulated by copper-dependent PERK kinase activity
Newton, S. E. B., Shi, X., Beratan, N. R., Perhacs, J., Arya, J., Bond, M. K., Gidalevitz, T., Akay, C., Brady, D. C., & Jordan‐Sciutto, K. L. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116318 · Cited by 8
Function and regulation of the mitochondrial stress response
Sheetz, J. B., Chandrasekhar, S., & Rapé, M. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-026-01769-9 · Cited by 8
Scanlan, A., Zhang, Z., Koneru, R., Reece, M. D., Gavegnano, C., Anderson, A. M. L., & Tyor, W. R. (2022) · Microorganisms · doi:10.3390/microorganisms10112244 · Cited by 8
The importance of prion research
Eid, S., Lee, S., Verkuyl, C. E., Almanza, D. L., Hanna, J., Shenouda, S., Belotserkovsky, A., Zhao, W., & Watts, J. C. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0018 · Cited by 8
Cytoplasmic RNA granules, ribostasis, and neurodegeneration
Benarroch, E. E. (2018) · Neurology · doi:10.1212/wnl.0000000000005172 · Cited by 8
Qin, K., Zhao, L., Solanki, A., Busch, C., & Mastrianni, J. A. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001262 · Cited by 8
Delineating the role of eIF2α in retinal degeneration
Starr, C. R., & Gorbatyuk, M. S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1641-y · Cited by 8
A novel ER stress regulator ARL6IP5 induces reticulophagy to ameliorate the prion burden
Kamble, K., Kumar, U., Aahra, H., Yadav, M., Bhola, S., & Gupta, S. (2024) · Autophagy · doi:10.1080/15548627.2024.2410670 · Cited by 7
Kunja, C., Kumar, V., Kodam, P., Gopu, C. D., & Maity, S. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1665272 · Cited by 7
Emerging perspectives in proteostasis: bridging mechanisms and therapeutics for human diseases
Borlepawar, A., Neu, M., Ma, Z., Deshpande, A., Bühringer, H., Hajieva, P., Frey, N., & Rangrez, A. Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02714-4 · Cited by 7
Bacterial Manipulation of the Integrated Stress Response: A New Perspective on Infection
Knowles, A. A., Campbell, S. G., Cross, N. A., & Stafford, P. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.645161 · Cited by 10
Neuron Scale Modeling of Prion Production with the Unfolded Protein Response
Adimy, M., Babin, L., & Pujo-Menjouet, L. (2022) · SIAM Journal on Applied Dynamical Systems · doi:10.1137/21m1443157 · Cited by 7
Vieira, F. G., Tassinari, V. R., Kidd, J. D., Moreno, A., Thompson, K., Perrin, S., Gill, A., & Hatzipetros, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0292190 · Cited by 8
The role of prion strain diversity in the development of successful therapeutic treatments
Holec, S. A. M., Block, A. J., & Bartz, J. C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.001 · Cited by 8
Disruption of Endoplasmic Reticulum Proteostasis in Age-Related Nervous System Disorders
Medinas, D. B., Hazari, Y., & Hetz, C. A. (2021) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-67696-4_12 · Cited by 7
Tatara, J. M., da Rosa, R. L., Varela, A. P. M., Teixeira, T. F., Sesterheim, P., Gris, A., Driemeier, D., Moraes, A. N. S., Berger, M., Peña, R. D., et al. (2023) · Archives of Virology · doi:10.1007/s00705-022-05629-x · Cited by 7
Menéndez‐Valle, I., Cachán-Vega, C., Boga, J. A., González‐Blanco, L., Antuña, E., Potes, Y., Caballero, B., Vega‐Naredo, I., Sáiz, P. A., Bobes, J., et al. (2023) · Antioxidants · doi:10.3390/antiox12111948 · Cited by 7
Prion-induced neurotoxicity: Possible role for cell cycle activity and DNA damage response
Bujdoso, R. (2015) · World Journal of Virology · doi:10.5501/wjv.v4.i3.188 · Cited by 7
CPEB4 links the clock and the UPR to protect the liver
Moore, P. C., & Oakes, S. A. (2017) · Nature Cell Biology · doi:10.1038/ncb3460 · Cited by 7
Integrated Stress Response (ISR) Modulators in Vascular Diseases
Kalinin, A., Zubkova, E., Beloglazova, I. B., Parfyonova, Y. V., & Menshikov, M. Y. (2025) · Cells · doi:10.3390/cells15010002 · Cited by 6
Rozpędek‐Kamińska, W., Piotrzkowska, D., Galita, G., Pytel, D., Kucharska, E., Dziki, Ł. A., Dziki, A. J., & Majsterek, I. (2022) · Polish Journal of Surgery · doi:10.5604/01.3001.0015.7948 · Cited by 6
Navigating the landscape of the unfolded protein response in CD8+ T cells
Nair, K. A., & Liu, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427859 · Cited by 6
Protein Homeostasis Dysregulation in Pathogenesis of Neurodegenerative Diseases
Kukharsky, M. S., Everett, M. W., Lytkina, O. A., Raspopova, M. A., Kovrazhkina, E. A., Овчинников, Р. К., Antohin, A., & Московцев, А. А. (2022) · Molecular Biology · doi:10.1134/s0026893322060115 · Cited by 6
Identification of the internal ribosome entry sites (IRES) of prion protein gene
Luo, X., Song, Q., Yu, J., Song, J., Wang, X., Xia, D., Sun, P., & Han, J. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.014 · Cited by 6
Nakagawa, K., Ueda, M., Itoh, M., Islam, S., Tana, T., & Nakagawa, T. (2017) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000234 · Cited by 6
Restelli, E., Chiesa, R., Masone, A., & Sallese, M. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.243708 · Cited by 6
Hoffman, T. E., Hanneman, W. H., & Moreno, J. A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.590045 · Cited by 6
Self-citationDai, E., Sun, D., Zhao, Y., Zhang, M., Wu, Y., & Ding, J. (2026) · The FASEB Journal · doi:10.1096/fj.202503547r · Cited by 5
Translating protein phosphatase research into treatments for neurodegenerative diseases
Sundaram, J. R., Lee, I. C. J., & Shenolikar, S. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160157 · Cited by 5
Mercer, R. C. C., McDonald, A. J., Bove‐Fenderson, E., Fang, C., Wu, B., & Harris, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00002-x · Cited by 5
Αnti-prion effects of anthocyanins
Christoudia, N., Bekas, N., Kanata, Ε., Chatziefsthathiou, A., Pettas, S., Karagianni, K., Correia, S., Schmitz, M., Zerr, I., Tsamesidis, I., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103133 · Cited by 5
Giltrap, A. M., Morris, N., Dong, Y. Y., Cochrane, S. A., Krülle, T. M., Hoekman, S., Semmelroth, M., Wollnik, C., Palmai‐Pallag, T., Carpenter, E. P., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c01506 · Cited by 5
Disparity among neural injury models and the unfolded protein response.
Logsdon, A. F., Lucke-Wold, B. P., Rosen, C. L., & Huber, J. D. (2014) · PubMed · Cited by 5
Microdissection and transcriptional profiling
Majer, A., & Booth, S. A. (2014) · Prion · doi:10.4161/pri.27729 · Cited by 6
Control of translation in the cold: implications for therapeutic hypothermia
Knight, J. R. P., & Willis, A. E. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150052 · Cited by 5
Self-citationTransmissible Spongiform Encephalopathies
Wısnıewskı, T., & Goñi, F. (2016) · Springer eBooks · doi:10.1007/978-3-319-33189-8_7 · Cited by 5
Calcineurin Activity Is Increased in Charcot-Marie-Tooth 1B Demyelinating Neuropathy
Sidoli, M., Reed, C. B., Scapin, C., Paez, P. M., Cavener, D. R., Kaufman, R. J., D’Antonio, M., Feltri, M. L., & Wrabetz, L. G. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2384-20.2021 · Cited by 5
Shott, R. H., Majer, A., Frost, K. L., Booth, S. A., & Schang, L. M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-160 · Cited by 5
Dysregulation of Neuronal Protein Synthesis in Alzheimer’s Disease
Ma, T. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190686307.013.18 · Cited by 5
Nutraceuticals in brain health
Haldar, S., Ghosh, S., Kumar, V., Saini, S., Debrupa Lahiri, A., & Roy, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00029-x · Cited by 5
Ghura, S., Beratan, N. R., Shi, X., Alvarez-Periel, E., Newton, S. E. B., Akay, C., & Jordan‐Sciutto, K. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-74362-z · Cited by 4
Lavigna, G., Grasso, A., Pasini, C., Grande, V., Mignogna, L., Restelli, E., Masone, A., Fracasso, C., Lucchetti, J., Gobbi, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317404 · Cited by 4
Lim, K. M., Hwang, J., & Koh, H. C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05441-z · Cited by 4
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation
Kanellos, G., Giacomelli, C., Raven, A., Vlahov, N., Jin, H., Herviou, P., Malla, S. B., Nasreddin, N., Centeno, P. P., Alexandrou, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02408-7 · Cited by 4
Control and regulation of mRNA translation
Mead, E. J., Masterton, R. J., von der Haar, T., Tuite, M. F., & Smales, C. M. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130259 · Cited by 4
Molecular Investigation of the Unfolded Protein Response in Select Human Tauopathies
Pitera, A. P., Hartnell, I. J., Scullard, L., Williamson, K. L., Boche, D., O'Connor, V. M., & Deinhardt, K. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210050 · Cited by 4
Garzón, D. N., Castillo, Y., Navas-Zuloaga, M. G., Darwin, L. J., Hardin, A., Culik, N., Yang, A., Castillo-Garsow, C. W., Rı́os-Soto, K. R., Arriola, L. M., et al. (2021) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2021.110797 · Cited by 5
Identifying therapeutic targets and treatments in model systems
Lasmézas, C. I., & Gabizon, R. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00022-2 · Cited by 4
Maladies neurodégénératives et stress oxydant
Lévy, E. (2020) · theses.fr (ABES) · doi:10.70675/75371581z194fz4cb4zb457z91bf72dc0320 · Cited by 4
Smits, J. F. M., Ligthart, T., Jorge‐Oliva, M., Middelhoff, S., Schipper, F., Pita-Illobre, D., Li, K. W., & Scheper, W. (2026) · Science Advances · doi:10.1126/sciadv.aea8940 · Cited by 3
Diverse stresses differentially regulate rRNA biogenesis and mRNA translation
Aldrich, A., Thomas, R., Blower, M. D., & Lyons, S. M. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag499 · Cited by 3
Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration
Hatstat, A. K., Pupi, M. D., Reinhart, M. C., & McCafferty, D. G. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00524 · Cited by 3
Liu, W., Xia, S., Yao, F., Huo, J., Qian, J., Liu, X., Bai, L., Song, Y., & Qian, J.-Z. (2024) · Molecular and Cellular Biology · doi:10.1080/10985549.2024.2347937 · Cited by 3
Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes
Dalle, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126425 · Cited by 3
Herholz, K., McMahon, A. W., Thompson, J. C., Jones, M. S., Boutin, H., Gregory, J., Parker, C. A., & Hinz, R. (2024) · Molecular Imaging and Biology · doi:10.1007/s11307-024-01965-3 · Cited by 3
Noori, H., Alazzeh, Z. J., Rehman, O. U., Idrees, M., Marsool, M. D. M., Rehman, K. A., Gohil, K. M., Ahmad, S. S., Subash, T., & Dixon, K. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07766-4 · Cited by 3
Experimental models of human prion diseases and prion strains
Diack, A. B., & Bartz, J. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00004-0 · Cited by 3
Akay, C., Newton, S. E. B., Dombroski, B. A., Kallianpur, A. R., Bharti, A., Franklin, D. R., Schellenberg, G. D., Heaton, R. K., Grant, I., Ellis, R. J., et al. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10125-x · Cited by 3
Autoimmune Attack Takes Your Breath Away
Lindström, T. M., & Robinson, W. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007233 · Cited by 3
Misfolding leads the way to unraveling signaling pathways in the pathophysiology of prion diseases
Puig, B., Altmeppen, H. C., & Glatzel, M. (2016) · Prion · doi:10.1080/19336896.2016.1244593 · Cited by 3
Liu, Y., Boone, M., Walter, P., & Costa‐Mattioli, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15754-7.00085-7 · Cited by 2
Xenopus laevis as a Model to Identify Translation Impairment
de Broucker, A., Semaille, P., Cailliau, K., Martoriati, A., Comptdaer, T., Bodart, J., Destée, A., & Chartier‐Harlin, M. (2015) · Journal of Visualized Experiments · doi:10.3791/52724 · Cited by 2
A PERK for the therapy of prion disease
Harrison, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4185 · Cited by 2
Tjalkens, R. B., Streifel, K. M., & Moreno, J. A. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00184 · Cited by 2
Self-citationCyclophillin A deficiency accelerates RML-induced prion disease
Bouybayoune, I., Comerio, L., Pasetto, L., Bertani, I., Bonetto, V., & Chiesa, R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104498 · Cited by 2
Potencjalne zastosowanie terapeutyczne inhibitorów PERK
Basak, J., Rozpędek‐Kamińska, W., Pytel, D., & Majsterek, I. (2019) · Postępy Biochemii · doi:10.18388/pb.2019_262 · Cited by 2
PKR-like ER kinase (PERK) Haplotypes Are Associated with Depressive Symptoms in People with HIV
Haddadi, S., Jordan-Sciutto, K. L., Akay, C., Grelotti, D., Letendre, S. L., Tang, B., & Ellis, R. J. (2023) · Journal of Neurology and Psychology · doi:10.13188/2332-3469.1000049 · Cited by 2
Fornara, B., Igel‐Egalon, A., Béringue, V., Martin, D., Sibille, P., Pujo-Menjouet, L., & Rézaei, H. (2024) · iScience · doi:10.1016/j.isci.2024.111381 · Cited by 2
Targeting the endoplasmic reticulum in prion disease treatment: breakthroughs and challenges
Kanemoto, S. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s74357 · Cited by 2
Rubenstein, R., Petersen, R. B., & Wısnıewskı, T. (2016) · ASM Press eBooks · doi:10.1128/9781555818722.ch71 · Cited by 2
Ильинский, Н. С., Nesterov, S. V., Shestoperova, E. I., Fonin, A. V., Уверский, В. Н., & Gordeliy, V. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521030040 · Cited by 2
Rozpędek‐Kamińska, W., Basak, J., Sokołowski, I., Wojtczak, R., Pytel, D., Diehl, J. A., & Majsterek, I. (2019) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2019.03.003 · Cited by 2
Stefani, I. C., de Thé, F.-X. B., Kontoravdi, C., & Polizzi, K. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112001 · Cited by 2
Neuroprotective Role of Nutritional Supplementation in Athletes
Chawla, V., Mishra, S., Singh, V. J., & Chawla, P. A. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666211209144721 · Cited by 2
Abbott, N. J. (2015) · Wiley eBooks · doi:10.1002/9781118788523.ch26 · Cited by 2
NOTCH1 and UPR signaling in embryonic heart development under maternal high-fat diet influence
Shi, Y., Li, B., & Shi, Q. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1620495 · Cited by 1
Mastrianni, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00025-8 · Cited by 1
A CONTRIBUIÇÃO GENÉTICA NO DESENVOLVIMENTO DE DOENÇAS PRIÔNICAS: REVISÃO SISTEMÁTICA
de Freitas, Y. B. B., Pimentel, A. L. M. R., Ayres, C. K. A. A., Bocchi, G. S., Diniz, H. C., Albernaz, V. R., Correia, D. V., & Alves, B. C. (2023) · Revista Foco · doi:10.54751/revistafoco.v16n6-096 · Cited by 1
Coşkuntan, İ., Paçal, F. P., Coşan, F., Çetin, E. A., Deniz, G., Üstek, D., Ekmekçi, S. S., Abacı, N., & Gül, A. (2025) · Rheumatology International · doi:10.1007/s00296-025-05972-7 · Cited by 1
Pathological and Functional Brain Amyloids: A New Concept Explaining the Differences
Galkin, A. P., Mitkevich, V. A., Makarov, A. А., Valina, A. A., & Sysoev, E. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110459 · Cited by 1
Zhang, Z., Wen, W., Lin, H., Hu, D., Li, H., & Luo, J. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106108 · Cited by 1
Stoian, I. I., Nistor, D., Levai, M. C., Popa, D. I., & Popescu, R. (2026) · Biomedicines · doi:10.3390/biomedicines14010126 · Cited by 1
Progressive Supranuclear Palsy PERK Haplotype B Selectively Translates DLX1 Promoting Tau Toxicity
Lessard, C. B., Rubio-Rubio, D., Tolton, S. G., Criado‐Marrero, M., Ravi, S., Garza, T. N., Koren, J., Phillips, J., Bagchi, P., McFarland, K. N., et al. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.1727-25.2026 · Cited by 1
eIF5A and polyamines restrict mRNA levels in response to ribosome stalls
Wohlenberg, C., Monem, P. C., Barbosa, N., Frydman, J., & Arribere, J. A. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2533876123 · Cited by 1
Neurodegeneration halted with oral therapy in mice
Jones, B. L. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.226 · Cited by 1
Lodhi, S. K., Mirza, M., & Khawaja, A. M. (2017) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000000558 · Cited by 1
Revisión de una serie de casos de enfermedad de Creutzfeldt-Jakob en un hospital de tercer nivel
Sancho, D. V., Fernández, F. G., Luque-Ambrosiani, A. C., Hernández-Chamorro, F. J., Macías, E. F., & Arjona, M. (2023) · Revista de Neurología · doi:10.33588/rn.7712.2023257 · Cited by 1
Endoplasmic Reticulum Stress and Protein Misfolding in Neurodegenerative Diseases
Samaddar, S., Redhwan, M. A. M., & Eraiah, M. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_15 · Cited by 1
Gannon, P. J. (2014) · Scholarly Commons (University of Pennsylvania) · Cited by 1
Past, Present and Potential Future Prion Disease Treatment Strategies
Skinner, P. J., & Seelig, D. M. (2017) · InTech eBooks · doi:10.5772/67172 · Cited by 1
ER Stress Signaling in Alzheimer's Disease
Rahman, M. M., Shrestha, L., & Gulshan, M. A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch007 · Cited by 1
Metadata
- Authors
- Moreno, J. A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J. M., Ortori, C. A., Willis, A. E., Fischer, P. M., Barrett, D. A., & Mallucci, G. R.
- Affiliations
- University of Leicester (GB)
- GlaxoSmithKline (United States) (US)
- University of Nottingham (GB)
- Corresponding author
- Mallucci, Giovanna R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2013-10-09
- Volume
- 5
- Issue
- 206
- Pages
- 206ra138-206ra138
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2010375635
- Cited by
- 589
- References
- 29
- Citations by year
- 2026: 22 · 2025: 27 · 2024: 21 · 2023: 29 · 2022: 32 · 2021: 42 · 2020: 59 · 2019: 46 · 2018: 54 · 2017: 72 · 2016: 54 · 2015: 58 · 2014: 58 · 2013: 13
- FWCI
- 27.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- prion disease, unfolded protein response, protein synthesis inhibition, neurodegeneration, oral drug therapy, neuroprotection, prion replication, synaptic failure, neurodegenerative disease treatment
- MeSH terms
- Adenine, Administration, Oral, Animals, Blood-Brain Barrier, Brain, Indoles, Nerve Degeneration, Phosphorylation, Prions, Synapses, Protein Biosynthesis, Eukaryotic Initiation Factor-2, Prion Diseases, Neuroprotective Agents, eIF-2 Kinase, Mice, Unfolded Protein Response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review